Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 1 | ||
Ligand | BDBM204269 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ERK2 (20 pM) Kinase Assay | ||
pH | 7.5±n/a | ||
IC50 | 0.011±n/a nM | ||
Comments | extracted | ||
Citation | Bagdanoff, JT; Ding, Y; Han, W; Huang, Z; Jiang, Q; Jin, JX; Kou, X; Lee, P; Lindvall, M; Min, Z; Pan, Y; Pecchi, S; Pfister, KB; Poon, D; Rauniyar, V; Wang, XM; Zhang, Q; Zhou, J; Zhu, S Aminoheteroaryl benzamides as kinase inhibitors US Patent US9242996 Publication Date 1/26/2016 | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 1 | |||
Name: | Mitogen-activated protein kinase 1 | ||
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK | ||
Type: | Ser/Thr Protein Kinase | ||
Mol. Mass.: | 41392.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P28482 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM204269 | |||
n/a | |||
Name | BDBM204269 | ||
Synonyms: | US9242996, 343 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H27FIN5O2 | ||
Mol. Mass. | 575.4171 | ||
SMILES | NC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)CC1)c1cccc(I)c1 |r,wU:23.25,wD:20.21,2.2,(4.67,6.93,;3.33,6.16,;3.33,4.62,;2,3.85,;.67,4.62,;.67,6.16,;-.67,3.85,;-.67,2.31,;-2,1.54,;-3.33,2.31,;-3.33,3.85,;-2,4.62,;-2,6.16,;-4.67,1.54,;-4.67,,;-6,-.77,;-7.34,,;-7.34,1.54,;-6,2.31,;-6,3.85,;-6,-2.31,;-7.34,-3.08,;-7.34,-4.62,;-6,-5.39,;-6,-6.93,;-4.67,-4.62,;-4.67,-3.08,;4.67,3.85,;6,4.62,;7.34,3.85,;7.34,2.31,;6,1.54,;6,,;4.67,2.31,)| | ||
Structure |